Background: The purpose was to determine what factors help predict benefit from preoperative MRI.
Methods: We conducted an IRB approved retrospective review of patients with breast cancer who underwent preoperative MRI (2018-2021). Patients were divided into a cohort of no new disease detected on MRI versus new disease detected.